Pharmacokinetics of cefquinome in red-eared slider turtles (Trachemys scripta elegans) after single intravenous and intramuscular injections

ArticleAçık Erişim

Özet

The purpose of this study was to evaluate the pharmacokinetics of cefquinome (CFQ) following single intravenous (IV) or intramuscular (IM) injections of 2 mg/kg body weight in red-eared slider turtles. Plasma concentrations of CFQ were determined by high-performance liquid chromatography and analyzed using noncompartmental methods. The pharmacokinetic parameters following IV injection were as follows: elimination half-life (t1/2λz) 21.73 ± 4.95 hr, volume of distribution at steady-state (Vdss) 0.37 ± 0.11 L/kg, area under the plasma concentration–time curve (AUC0–∞) 163 ± 32 μg hr−1 ml−1, and total body clearance (ClT) 12.66 ± 2.51 ml hr−1 kg−1. The pharmacokinetic parameters after IM injection were as follows: peak plasma concentration (Cmax) 3.94 ± 0.84 μg/ml, time to peak concentration (Tmax) 3 hr, t1/2λz 26.90 ± 4.33 hr, and AUC0–∞ 145 ± 48 μg hr−1 ml−1. The bioavailability after IM injection was 88%. Data suggest that CFQ has a favorable pharmacokinetic profile with a long half-life and a high bioavailability in red-eared slider turtles. Further studies are needed to establish a multiple dosage regimen and evaluate clinical efficacy. © 2017 John Wiley & Sons Ltd

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14224Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1111/jvp.12448Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorUney, K.
dc.contributor.authorAltan, F.
dc.contributor.authorCetin, G.
dc.contributor.authorAboubakr, M.
dc.contributor.authorDik, B.
dc.contributor.authorSayın, Z.
dc.contributor.authorEr, A.
dc.contributor.authorElmas, M.
dc.date.accessioned2026-10-18T20:29:00.835838642Z
dc.date.available2026-10-18T20:29:00.835838642Z
dc.date.issued2018
dc.description.abstractThe purpose of this study was to evaluate the pharmacokinetics of cefquinome (CFQ) following single intravenous (IV) or intramuscular (IM) injections of 2 mg/kg body weight in red-eared slider turtles. Plasma concentrations of CFQ were determined by high-performance liquid chromatography and analyzed using noncompartmental methods. The pharmacokinetic parameters following IV injection were as follows: elimination half-life (t1/2λz) 21.73 ± 4.95 hr, volume of distribution at steady-state (Vdss) 0.37 ± 0.11 L/kg, area under the plasma concentration–time curve (AUC0–∞) 163 ± 32 μg hr−1 ml−1, and total body clearance (ClT) 12.66 ± 2.51 ml hr−1 kg−1. The pharmacokinetic parameters after IM injection were as follows: peak plasma concentration (Cmax) 3.94 ± 0.84 μg/ml, time to peak concentration (Tmax) 3 hr, t1/2λz 26.90 ± 4.33 hr, and AUC0–∞ 145 ± 48 μg hr−1 ml−1. The bioavailability after IM injection was 88%. Data suggest that CFQ has a favorable pharmacokinetic profile with a long half-life and a high bioavailability in red-eared slider turtles. Further studies are needed to establish a multiple dosage regimen and evaluate clinical efficacy. © 2017 John Wiley & Sons Ltd
dc.identifier.doi10.1111/jvp.12448
dc.identifier.eissn1365-2885
dc.identifier.endpagee44
dc.identifier.issn0140-7783
dc.identifier.issue1
dc.identifier.pmid28833214
dc.identifier.scopus2-s2.0-85040036761
dc.identifier.startpagee40
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14224
dc.identifier.volume41
dc.identifier.wosWOS:000419403100007
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.relation.ispartofJournal of Veterinary Pharmacology and Therapeutics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcefquinome
dc.subjectpharmacokinetics
dc.subjectred-eared slider turtle
dc.subjectAnimals
dc.subjectAnti-Bacterial Agents
dc.subjectCephalosporins
dc.subjectHalf-Life
dc.subjectInjections, Intramuscular
dc.subjectInjections, Intravenous
dc.subjectTurtles
dc.subjectantiinfective agent
dc.subjectcephalosporin derivative
dc.subjectanimal experiment
dc.subjectarea under the curve
dc.subjectArticle
dc.subjectbird
dc.subjectclinical effectiveness
dc.subjectdrug absorption
dc.subjectdrug bioavailability
dc.subjectdrug blood level
dc.subjectdrug mechanism
dc.subjectelimination half-life
dc.subjecthigh performance liquid chromatography
dc.subjectmammal
dc.subjectmaximum plasma concentration
dc.subjectnonhuman
dc.subjectplasma clearance
dc.subjectpriority journal
dc.subjectsingle drug dose
dc.subjecttime to maximum plasma concentration
dc.titlePharmacokinetics of cefquinome in red-eared slider turtles (Trachemys scripta elegans) after single intravenous and intramuscular injections
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus9
rdl.citation.wos8
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)